News Releases

1 ... 35 36 37 38 39

November 20, 2015

From The President’s Desk

As we fast approach the holiday season, OrganiGram would like to do its part to give back to our community of valued clients.
October 21, 2015

OrganiGram Provides Shareholder Update and Q1 Guidance

Moncton, N.B. October 21, 2015 – OrganiGram Holdings Inc. (TSX-V: OGI) (OTC US:OGRMF) (the “Company”) is pleased to provide an update to shareholders.
October 19, 2015

OrganiGram Holdings Inc. Comments on Colorado Pesticide Lawsuit

Moncton, N.B. October 19, 2015 – OrganiGram Holdings Inc. (TSX-V: OGI) (OTC US: OGRMF) (the “Company”) would like to provide its position pertaining to the medical marijuana industry’s use of...
October 12, 2015

From The President’s Desk

Since the beginning of our journey as Atlantic Canada’s Original Licensed Producer, we have made tremendous progress in moving forward with our vision, consistently meeting the high demand for our...
September 2, 2015

OrganiGram Announces The Approval Of Four Additional Grow Rooms

Moncton, N.B. September 02, 2015 – OrganiGram Holdings Inc. (TSX-V: OGI) (OTC US:OGRMF) (the “Company”) is pleased to announce that the Company recently received regulatory approval to activate four more...

1 ... 35 36 37 38 39

Have a question for us?

Call 1-844-644-4726 (1-844-OGI-GRAM) and the folks on our client support team like Dan, Janice and Jeff can answer any question you have.

Monday to Thursday: 8:30 AM to 8:00 PM 
Friday: 8:30 AM to 6:30 PM 
Fax: 1-855-267-1386

Stay informed. #DiscoverOGI.

Interested in keeping up with Organigram news? Subscribe to our mailing lists and stay up-to-date on Organigram products, patient programs, company news and investor relations. 

By signing up, I acknowledge that I can unsubscribe at any time, and I accept the terms, conditions and privacy policy.

If you wish to receive newsletters from Organigram Holdings Inc. and its subsidiaries, please provide your email address and click on the “Subscribe” button above. If we do not receive your consent, we may be unable to send you communications. If you have any questions, or if you wish to withdraw your consent at any time, please feel free to contact us by phone at 1-844-644-4726 or by email at By clicking “Subscribe” I consent to receipt of communications as indicated above.